Jon Belsher, MD’s Post

View profile for Jon Belsher, MD, graphic

I Guide Medtech and Healthtech Founders in Building and Scaling Solutions by Combining 30+ Years of Clinical Practice, Executive Leadership, and Military Precision. Former CEO & White House | Board Member | Veteran

⏱️ Five minutes can feel like a lifetime when you’re watching someone bleed out. As a former flight surgeon and ICU specialist, I’ve seen firsthand the devastating impact of severe hemorrhage. The FDA’s recent approval of Traumagel, an algae-derived gel that stops bleeding in seconds, could be a game-changer. ⚡️ Unlike current treatments that require manual pressure and take minutes to work, Traumagel is advertised to work almost instantly. This innovation could dramatically reduce preventable deaths from severe injuries – particularly on the battlefield, where an estimated 91% of fatalities are due to hemorrhage. How do innovations like this change the way you think about emergency care? #IndustryInsights #EmergencyCare #HealthcareInnovation Photo: medical readiness training exercise with a moulage patient (luckily)

  • No alternative text description for this image
Matthew Champagne

U.S. Air Force Pararescue Team Leader/Project Manager Standards & Evaluation

2mo

Traumagel is a great idea and concept. Excited to see the data as time unfolds on its efficacy and any reported issues from surgeons as patients arrive at hospitals. Also, whoever did that moukage gets an A+

Dona Marie Iversen RN, MS, CCM, BC~NE

Visionary Healthcare Executive, Veteran

1mo

A++ on the moulage! Traumagel is a long over due necessity in the civilian & military sectors! Hopefully the scientific data supports.

Jennifer Belsher

Leveraging a blend of strategic marketing insights and physician executive expertise, We drive impactful initiatives that drive growth, innovation, and positive change in the healthcare landscape.

2mo

This is amazing!

See more comments

To view or add a comment, sign in

Explore topics